These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11812511)

  • 1. Butorphanol and nalbuphine in opioid-dependent humans under a naloxone discrimination procedure.
    Oliveto A; Sevarino K; McCance-Katz E; Feingold A
    Pharmacol Biochem Behav; 2002; 71(1-2):85-96. PubMed ID: 11812511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discrimination of butorphanol and nalbuphine in opioid-dependent humans.
    Preston KL; Bigelow GE; Liebson IA
    Pharmacol Biochem Behav; 1990 Nov; 37(3):511-22. PubMed ID: 1708145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonidine and yohimbine in opioid-dependent humans responding under a naloxone novel-response discrimination procedure.
    Oliveto A; Sevarino K; McCance-Katz E; Benios T; Poling J; Feingold A
    Behav Pharmacol; 2003 Mar; 14(2):97-109. PubMed ID: 12658070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopaminergic activity and the discriminative stimulus effects of mu opioids in pigeons: importance of training dose and attenuation by the D3 agonist (+/-)-7-OH-DPAT.
    Cook CD; Picker MJ
    Psychopharmacology (Berl); 1998 Mar; 136(1):59-69. PubMed ID: 9537683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-choice discrimination in pigeons is based on relative efficacy differences among opioids.
    Walker EA; Picker MJ; Dykstra LA
    Psychopharmacology (Berl); 2001 Jun; 155(4):389-96. PubMed ID: 11441428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of mu-opioid agonists on cocaine- and food-maintained responding and cocaine discrimination in rhesus monkeys: role of mu-agonist efficacy.
    Negus SS; Mello NK
    J Pharmacol Exp Ther; 2002 Mar; 300(3):1111-21. PubMed ID: 11861822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of opioid partial agonist activity with a three-choice hydromorphone dose-discrimination procedure.
    Jones HE; Bigelow GE; Preston KL
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1350-61. PubMed ID: 10336526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of buprenorphine, butorphanol and nalbuphine on the initiation of intravenous cocaine self-administration in drug naive mice.
    Kuzmin AV; Gerrits MA; Zvartau EE; van Ree JM
    Eur Neuropsychopharmacol; 2000 Dec; 10(6):447-54. PubMed ID: 11115734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the delta opioid against BW373U86 in pigeons trained to discriminate fentanyl, bremazocine and water in a three-choice drug discrimination procedure.
    Negus SS; Morgan D; Cook CD; Picker MJ
    Psychopharmacology (Berl); 1996 Aug; 126(3):199-205. PubMed ID: 8876019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D-cycloserine-Naloxone interactions in opioid-dependent humans under a novel-response naloxone discrimination procedure.
    Oliveto A; Benios T; Gonsai K; Feingold A; Poling J; Kosten TR
    Exp Clin Psychopharmacol; 2003 Aug; 11(3):237-46. PubMed ID: 12940503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discriminative stimulus effects of buprenorphine in the rat.
    Holtzman SG
    Psychopharmacology (Berl); 1997 Apr; 130(3):292-9. PubMed ID: 9151365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminative stimulus effects of opioids in pigeons trained to discriminate fentanyl, bremazocine and water: evidence of pharmacological selectivity.
    Picker MJ; Cook CD
    Behav Pharmacol; 1997 Jun; 8(2-3):160-73. PubMed ID: 9833011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discriminative stimulus effects of butorphanol: influence of training dose on the substitution patterns produced by Mu, Kappa and Delta opioid agonists.
    Picker MJ; Benyas S; Horwitz JA; Thompson K; Mathewson C; Smith MA
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1130-41. PubMed ID: 8968334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discriminative stimulus effects of nalbuphine in nontreated and morphine-treated pigeons.
    Walker EA; Hawkins ER; Tiano MJ; Picker MJ; Dykstra LA
    Pharmacol Biochem Behav; 1999 Oct; 64(2):445-8. PubMed ID: 10515328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opiate receptor pharmacology: mixed agonist/antagonist narcotics.
    Hameroff SR
    Contemp Anesth Pract; 1983; 7():27-43. PubMed ID: 6136392
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug discrimination assessment of agonist-antagonist opioids in humans: a three-choice saline-hydromorphone-butorphanol procedure.
    Preston KL; Bigelow GE
    J Pharmacol Exp Ther; 1994 Oct; 271(1):48-60. PubMed ID: 7525929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NOP receptor mediates anti-analgesia induced by agonist-antagonist opioids.
    Gear RW; Bogen O; Ferrari LF; Green PG; Levine JD
    Neuroscience; 2014 Jan; 257():139-48. PubMed ID: 24188792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacology of antagonists of narcotic-induced respiratory depression. A brief review.
    Bowdle TA
    Acute Care; 1988; 12 Suppl 1():70-6. PubMed ID: 3278495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. kappa-Opioid receptor effects of butorphanol in rhesus monkeys.
    Vivian JA; DeYoung MB; Sumpter TL; Traynor JR; Lewis JW; Woods JH
    J Pharmacol Exp Ther; 1999 Jul; 290(1):259-65. PubMed ID: 10381785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonist effects of nalbuphine in opioid-dependent human volunteers.
    Preston KL; Bigelow GE; Liebson IA
    J Pharmacol Exp Ther; 1989 Mar; 248(3):929-37. PubMed ID: 2467983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.